Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.
Email alerts

Application overview

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Open research · Psilocybin & psilocin

Countries and organisations

Explore psilocybin trials by country, sponsor and research facility. Compare registry status, study-start trends, conditions and mapped research sites.

Free access · No subscription for research tools or data exports

Explore registry geography and organisations

Reset

9 trials match this view; 6 mapped facilities. Latest indexed registry check Oct 9, 2026 01:24 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.

Enrollment sum: 329 across 9 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.

Recorded study-start years

201411
202122
202333
202522
202611

Current indexed registry status

Recruiting33
Completed33
Not yet recruiting11
Terminated11
Withdrawn11

Reported research conditions

Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.

Matching trial records

9 matching registry records. Dates are registry milestones, not promised results announcements.
TrialSponsor and phaseStatusEnrollmentStart / primary completion / completionResearch workflow
Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study

NCT07360301

Well-Being, Psychological · Psychedelic Experiences
University of Wisconsin, Madison

PHASE1

Not yet recruiting

Registry updated 2026-09-29

120

ESTIMATED

2026-10
2028-02
2028-02
Role of Experience, Conscious Awareness, and Plasticity in Psilocybin's Behavioral Effects - Follow-Up Study (The RECAP 2 Study)

NCT06692192

Psilocybin
University of Wisconsin, Madison

PHASE1

Recruiting

Registry updated 2026-08-13

60

ESTIMATED

2025-08-07
2027-12
2027-12
Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of Psilocybin

NCT05866471

Healthy · Psychedelic Experiences · Vagus Nerve Stimulation
University of Wisconsin, Madison

PHASE1

Recruiting

Registry updated 2026-07-29

108

ESTIMATED

2025-01-27
2027-11
2028-01
Phase I Study of the Safety and Adjunctive Effects of Psilocybin in Adults With Opioid Use Disorder Maintained on a Buprenorphine/Naloxone Formulation

NCT04161066

Opioid Use Disorder
University of Wisconsin, Madison

PHASE1

Recruiting

Registry updated 2026-07-07

10

ESTIMATED

2021-01-13
2026-12
2026-12
Safety and Feasibility of Psilocybin in Methamphetamine Use Disorder in a Community-Based Sample

NCT05322954

Methamphetamine Use Disorder · Substance-Related Disorders · Chemically-Induced Disorders · Substance Use Disorders · Stimulant-Use Disorder
University of Wisconsin, Madison

PHASE1

Terminated

Registry updated 2026-05-12

5

ACTUAL

2023-03-03
2024-03-07
2024-03-07
Consciousness and Psilocybin Effects on Well-Being (The CoPE Study): Pilot Phase

NCT05592379

Healthy · Psychedelic Experiences · Sleep
University of Wisconsin, Madison

PHASE1

Completed

Registry updated 2025-05-16

6

ACTUAL

2023-11-07
2025-02-19
2025-02-19
Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult Volunteers

NCT04842045

Psychedelic Experiences · Amnesia
University of Wisconsin, Madison

PHASE1

Completed

Registry updated 2023-05-19

8

ACTUAL

2021-05-21
2022-11-17
2022-11-17
A Phase 1 Study Comparing the Pharmacokinetics and Safety of Intravenous and Oral Psilocybin

NCT05467761

Healthy
University of Wisconsin, Madison

PHASE1

Withdrawn

Registry updated 2023-05-15

0

ACTUAL

2023-06
2024-03
2024-03
Pharmacokinetics of Psilocybin in Normal Adult Volunteers

NCT02163707

Healthy
University of Wisconsin, Madison

PHASE1

Completed

Registry updated 2020-04-15

12

ACTUAL

2014-06
2015-12
2015-12

Reported research facilities

University of WisconsinMadison, Wisconsin, United States
UW School of Medicine and Public HealthMadison, Wisconsin, United States
University of Wisconsin - MadisonMadison, Wisconsin, United States
University of Wisconsin Hospital and ClinicsMadison, Wisconsin, United States
UWHealth, 600 Highland AvenueMadison, Wisconsin, United States
University of Wisconsin, School of PharmacyMadison, Wisconsin, United States

This list includes mapped sites of matching trials, including international sites; locations without usable coordinates are omitted. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.